Heart failure has become one of the top subjects in modern cardiology. The reasons for this are not only due to an aging population but the many new management tools that have entered the clinical arena these last years. Also, older drugs have been re-evaluated and newer ones have paved the way for clinicians to better control heart function. Devices offer remarkable new paths to treatment, especially for severe cases that were, until recently, considered hopeless. All these new approaches require repeated follow-up offering a new and special role for the practicing cardiologists in their everyday consultation. In addition, a new cohort of patients is being seen, including those receiving chemotherapy for malignant diseases. Finally, in this new series of clinical adventures for the clinician, one should not forget the benefit of exercise training as a new approach to the treatment of heart failure: this, on top of its specific efficacy in the treatment itself, also improves the quality of life of the patients, allowing them to feel better and realise that they still have a future ahead of them.
This series looks at Heart Failure and reviews constant evolution in our understanding - and treatment – of this condition.
D.L. Clement, Editor-in-chief, E-journal
Date
Title
Author(s)
Our mission: To reduce the burden of cardiovascular disease.